Observational study of various blood parameters in Long COVID patients.
- Conditions
- COVID-19
- Registration Number
- JPRN-UMIN000045053
- Lead Sponsor
- Hirahata Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Not provided
1)Those who have a current or previous serious disease such as brain disease,malignant tumor,immunological disease,diabetes,liver disease hepatitis,renal disease,heart disease,etc.,thyroid disease,adrenal disease,or other metabolic disease 2)Those who have donated more than 200 mL of blood within 1 month or 400 mL of blood within 3 months prior to the date of consent. 3)Those who have difficulty in complying with the recording of various questionnaires. 4)Others who are judged as unsuitable as subjects by the principal investigator or sub-investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Blood test 1-1.Plasma GSH,GSSG,low molecular weight thiol-bound GSH 1-2.Plasma malondialdehyde 1-3.Serum IL-6,TNF,IL-10 1-4.Peripheral blood including leukocyte image,AST,ALT,LDL,HDL,TG,FFA,BUN,creatinine,eGFR,Mg,Zn,Fe,ferritin,blood glucose,HbA1C,cortisol,25OHVD,vitamin C,high-sensitivity CRP,D Dimer 2.Questionnaire COVID-19 history,medical history,current medical history,family history,life history,indefinite complaints,etc.
- Secondary Outcome Measures
Name Time Method 3.General measurements age,gender,height,weight,BMI,etc. 4.Vital signs